Logo image of PAVM

PAVMED INC (PAVM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PAVM - US70387R4039 - Common Stock

6.58 USD
-2.17 (-24.8%)
Last: 1/16/2026, 8:00:02 PM
6.29 USD
-0.29 (-4.41%)
After Hours: 1/16/2026, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PAVM. PAVM was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PAVM has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, PAVM is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year PAVM has reported negative net income.
  • PAVM had a negative operating cash flow in the past year.
  • In the past 5 years PAVM reported 4 times negative net income.
  • In the past 5 years PAVM always reported negative operating cash flow.
PAVM Yearly Net Income VS EBIT VS OCF VS FCFPAVM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

  • PAVM has a Return On Assets of -1.56%. This is in the better half of the industry: PAVM outperforms 70.97% of its industry peers.
  • PAVM has a better Return On Equity (-1.66%) than 72.58% of its industry peers.
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROIC N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PAVM Yearly ROA, ROE, ROICPAVM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for PAVM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PAVM Yearly Profit, Operating, Gross MarginsPAVM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

3

2. Health

2.1 Basic Checks

  • PAVM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • PAVM has more shares outstanding than it did 1 year ago.
  • PAVM has less shares outstanding than it did 5 years ago.
  • PAVM has a better debt/assets ratio than last year.
PAVM Yearly Shares OutstandingPAVM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PAVM Yearly Total Debt VS Total AssetsPAVM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 36.28 indicates that PAVM is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of PAVM (36.28) is better than 98.92% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that PAVM is not too dependend on debt financing.
  • PAVM's Debt to Equity ratio of 0.19 is in line compared to the rest of the industry. PAVM outperforms 58.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 36.28
ROIC/WACCN/A
WACC9.74%
PAVM Yearly LT Debt VS Equity VS FCFPAVM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

  • A Current Ratio of 0.40 indicates that PAVM may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.40, PAVM is doing worse than 93.01% of the companies in the same industry.
  • PAVM has a Quick Ratio of 0.40. This is a bad value and indicates that PAVM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of PAVM (0.40) is worse than 93.01% of its industry peers.
Industry RankSector Rank
Current Ratio 0.4
Quick Ratio 0.4
PAVM Yearly Current Assets VS Current LiabilitesPAVM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

  • The earnings per share for PAVM have decreased strongly by -388.28% in the last year.
  • PAVM shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -99.28%.
  • Measured over the past years, PAVM shows a very strong growth in Revenue. The Revenue has been growing by 81.61% on average per year.
EPS 1Y (TTM)-388.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-704.17%
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.79% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, PAVM will show a very strong growth in Revenue. The Revenue will grow by 142.05% on average per year.
EPS Next Y94.12%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PAVM Yearly Revenue VS EstimatesPAVM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
PAVM Yearly EPS VS EstimatesPAVM Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PAVM. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PAVM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PAVM Price Earnings VS Forward Price EarningsPAVM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PAVM Per share dataPAVM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

  • PAVM's earnings are expected to grow with 26.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.79%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for PAVM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

PAVMED INC

NASDAQ:PAVM (1/16/2026, 8:00:02 PM)

After market: 6.29 -0.29 (-4.41%)

6.58

-2.17 (-24.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-23
Inst Owners9.31%
Inst Owner Change0%
Ins Owners8.64%
Ins Owner Change15.5%
Market Cap181.87M
Revenue(TTM)29.00K
Net Income(TTM)-595.00K
Analysts82.5
Price Target321.3 (4782.98%)
Short Float %1.91%
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-262.66%
Min EPS beat(2)-458.07%
Max EPS beat(2)-67.24%
EPS beat(4)2
Avg EPS beat(4)-4.76%
Min EPS beat(4)-458.07%
Max EPS beat(4)356.41%
EPS beat(8)4
Avg EPS beat(8)-9.4%
EPS beat(12)7
Avg EPS beat(12)-3.45%
EPS beat(16)7
Avg EPS beat(16)-6.47%
Revenue beat(2)0
Avg Revenue beat(2)-60.78%
Min Revenue beat(2)-80.39%
Max Revenue beat(2)-41.18%
Revenue beat(4)0
Avg Revenue beat(4)-60.36%
Min Revenue beat(4)-98.31%
Max Revenue beat(4)-21.57%
Revenue beat(8)0
Avg Revenue beat(8)-35.03%
Revenue beat(12)2
Avg Revenue beat(12)-31.9%
Revenue beat(16)2
Avg Revenue beat(16)-39.94%
PT rev (1m)2525%
PT rev (3m)2639.13%
EPS NQ rev (1m)-2900%
EPS NQ rev (3m)-2900%
EPS NY rev (1m)0%
EPS NY rev (3m)-166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-39.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6271.42
P/FCF N/A
P/OCF N/A
P/B 5.08
P/tB 5.08
EV/EBITDA N/A
EPS(TTM)-20.41
EYN/A
EPS(NY)-0.82
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0
BVpS1.29
TBVpS1.29
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.56%
ROE -1.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.06%
ROA(5y)-98.83%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.46%
Cap/Sales 72.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.4
Quick Ratio 0.4
Altman-Z 36.28
F-Score2
WACC9.74%
ROIC/WACCN/A
Cap/Depr(3y)25.15%
Cap/Depr(5y)202.92%
Cap/Sales(3y)138.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-388.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-704.17%
EPS Next Y94.12%
EPS Next 2Y26.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-99.28%
Revenue growth 3Y81.61%
Revenue growth 5YN/A
Sales Q2Q%-99.5%
Revenue Next Year-97.58%
Revenue Next 2Y-63.49%
Revenue Next 3Y268.29%
Revenue Next 5Y142.05%
EBIT growth 1Y63.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year93.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y93.75%
OCF growth 3YN/A
OCF growth 5YN/A

PAVMED INC / PAVM FAQ

What is the fundamental rating for PAVM stock?

ChartMill assigns a fundamental rating of 3 / 10 to PAVM.


What is the valuation status of PAVMED INC (PAVM) stock?

ChartMill assigns a valuation rating of 1 / 10 to PAVMED INC (PAVM). This can be considered as Overvalued.


Can you provide the profitability details for PAVMED INC?

PAVMED INC (PAVM) has a profitability rating of 1 / 10.


How financially healthy is PAVMED INC?

The financial health rating of PAVMED INC (PAVM) is 3 / 10.